UroGen Pharma Ltd. (URGN)
18.59
+0.11
(+0.60%)
USD |
NASDAQ |
Mar 19, 16:00
18.79
+0.20
(+1.08%)
Pre-Market: 08:25
UroGen Pharma Shareholders Equity (Quarterly) : -105.47M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| RadNet, Inc. | 1.090B |
| Zymeworks, Inc. | 268.50M |
| Xeris Biopharma Holdings, Inc. | 13.69M |
| Caribou Biosciences, Inc. | 122.18M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 200.46M |
| Total Liabilities (Quarterly) | 305.93M |
| Debt to Equity Ratio | -1.233 |
| Current Ratio | 4.008 |
| Net Debt Paydown Yield | -0.13% |